Huizhou Oule Technology Co., Ltd. – Trademark Portfolio
Entity Type: 99
Huizhou Oule Technology Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered and 2 are pending. Notable registered marks include OLOVOLOV and OLOVGLOBAL. The owner is based in Huizhou.
Area 205, 2/F, Bldg. 8, No. 9 Technology
Industrial Park, Daya Bay West District
Huizhou 516083 , CN
Showing of trademarks Trademarks
Trademark Classifications
Huizhou Oule Technology Co., Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Huizhou Oule Technology Co., Ltd. have?
Huizhou Oule Technology Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 pending.
What trademark classes does Huizhou Oule Technology Co., Ltd. file in?
Huizhou Oule Technology Co., Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 7 (Machinery). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Huizhou Oule Technology Co., Ltd.'s most well-known trademarks?
Huizhou Oule Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as OLOVOLOV and OLOVGLOBAL. These are among 2 currently registered trademarks in the portfolio.
What is Huizhou Oule Technology Co., Ltd.'s trademark registration success rate?
Huizhou Oule Technology Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 2 applications are pending review.